Haematopoietic stem cell health in sickle cell disease and its implications for stem cell therapies and secondary haematological disorders (2024)
Attributed to:
Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.blre.2023.101137
Publication URI: http://dx.doi.org/10.1016/j.blre.2023.101137
Type: Journal Article/Review
Parent Publication: Blood Reviews